Abbott Laboratories
ABT
$105.90
-$0.02-0.02%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 54.31% | 0.07% | -31.86% | -46.14% | -48.06% |
| Total Depreciation and Amortization | 0.74% | 1.10% | -2.68% | -2.07% | -8.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.27% | -4.88% | -7.04% | -7.87% | 104.97% |
| Change in Net Operating Assets | 150.64% | -222.85% | -93.01% | 16.42% | 358.82% |
| Cash from Operations | 30.61% | -32.48% | -50.08% | -44.65% | -24.16% |
| Capital Expenditure | -23.77% | -19.91% | -33.77% | -18.38% | 0.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -16.67% | -- | -- |
| Other Investing Activities | -213.64% | -35.29% | 19.40% | -110.26% | 61.40% |
| Cash from Investing | -30.38% | -30.99% | -359.47% | -28.33% | 5.81% |
| Total Debt Issued | 120.00% | -100.00% | -90.91% | -- | 150.00% |
| Total Debt Repaid | -- | -150,500.00% | 1,200.00% | 94.41% | 100.00% |
| Issuance of Common Stock | -17.07% | -1.75% | 50.00% | 5.08% | -50.00% |
| Repurchase of Common Stock | 62.19% | 99.75% | -8,420.00% | 76.59% | 29.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.90% | -7.51% | -7.49% | -6.97% | -3.13% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -40.84% | -51.65% | -58.55% | 63.12% | 22.75% |
| Foreign Exchange rate Adjustments | -50.98% | 69.79% | 61.97% | 233.33% | 492.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.07% | -271.39% | -205.07% | 66.05% | -42.05% |
